Behavioral approach to nondyskinetic dopamine antagonists: identification of seroquel

…, BM Migler, CJ Ohnmacht, AL Needles…

Index: Warawa; Migler; Ohnmacht; Needles; Gatos; McLaren; Nelson; Kirkland Journal of Medicinal Chemistry, 2001 , vol. 44, # 3 p. 372 - 389

Full Text: HTML

Citation Number: 40

Abstract

A great need exists for antipsychotic drugs which will not induce extrapyramidal symptoms (EPS) and tardive dyskinesias (TDs). These side effects are deemed to be a consequence of nonselective blockade of nigrostriatal and mesolimbic dopamine D2 receptors. Nondyskinetic clozapine (1) is a low-potency D2 dopamine receptor antagonist which appears to act selectively in the mesolimbic area. In this work dopamine antagonism was ...